ES8605522A1 - Un procedimiento para preparar derivados de furo (3,2-c) piridinas. - Google Patents

Un procedimiento para preparar derivados de furo (3,2-c) piridinas.

Info

Publication number
ES8605522A1
ES8605522A1 ES547315A ES547315A ES8605522A1 ES 8605522 A1 ES8605522 A1 ES 8605522A1 ES 547315 A ES547315 A ES 547315A ES 547315 A ES547315 A ES 547315A ES 8605522 A1 ES8605522 A1 ES 8605522A1
Authority
ES
Spain
Prior art keywords
group
hydrogen
furo
phenyl
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES547315A
Other languages
English (en)
Other versions
ES547315A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Publication of ES8605522A1 publication Critical patent/ES8605522A1/es
Publication of ES547315A0 publication Critical patent/ES547315A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Mushroom Cultivation (AREA)
  • Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR DERIVADOS DE FURO 2,3-C PIRIDINAS. COMPRENDE: A) PIRROLIDINAR A UNA OXO-4-PIPERIDINA DE FORMULA (II), EN PRESENCIA DE ACIDO P-TOLUENSULFONICO Y EN TOLUENO, PARA REALIZAR UN COMPUESTO DE FORMULA (III); B) TRATAR A (III) CON UNA CETONA BROMADA EN POSICION A DE FORMULA (IV); Y C) CILAR A (V) CON CLH A LA TEMPERATURA DE REFLUJO, PARA OBTENER UN COMPUESTO DE FORMULA (I). SIENDO: R1, FENILO, HALOFENILO, METILFENILO, ETILFENILO, O TRIFLUOROMETILFENILO; R2, HIDROGENO, BENCILO O FENILO; Y R3, BENCILO. SE UTILIZA PARA EL TRATAMIENTO DE LAS ENCEFALOPATIAS METABOLICAS Y DE LOS ESTADOS DEPRESIVOS.
ES547315A 1984-09-27 1985-09-26 Un procedimiento para preparar derivados de furo (3,2-c) piridinas. Expired ES8605522A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8414842A FR2570701B1 (fr) 1984-09-27 1984-09-27 Derives de furo(3,2-c)pyridines, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
ES8605522A1 true ES8605522A1 (es) 1986-03-16
ES547315A0 ES547315A0 (es) 1986-03-16

Family

ID=9308136

Family Applications (1)

Application Number Title Priority Date Filing Date
ES547315A Expired ES8605522A1 (es) 1984-09-27 1985-09-26 Un procedimiento para preparar derivados de furo (3,2-c) piridinas.

Country Status (19)

Country Link
US (1) US4661498A (es)
EP (1) EP0178201B1 (es)
JP (1) JPS61106577A (es)
KR (1) KR860002508A (es)
AT (1) ATE40554T1 (es)
AU (1) AU573390B2 (es)
CA (1) CA1291994C (es)
DE (1) DE3568045D1 (es)
DK (1) DK158953C (es)
ES (1) ES8605522A1 (es)
FI (1) FI82054C (es)
FR (1) FR2570701B1 (es)
GR (1) GR852356B (es)
HU (1) HU192365B (es)
IL (1) IL76535A0 (es)
NO (1) NO162821C (es)
NZ (1) NZ213620A (es)
PT (1) PT81206B (es)
ZA (1) ZA857457B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2566775B1 (fr) * 1984-06-27 1986-10-31 Synthelabo Derives de tetrahydro-4,5,6,7 furo ou 1h-pyrrolo(2,3-c)pyridine, leur preparation et leur application en therapeutique
FR2619112B1 (fr) * 1987-08-07 1989-11-17 Synthelabo Derives de (piperidinyl-4)methyl-2 benzo(b)furo(2,3-c) pyridines, leur preparation et leur application en therapeutique
FR2635977B1 (fr) * 1988-09-07 1992-05-15 Synthelabo Utilisation de derives de tetrahydro-4,5,6,7 furopyridines pour obtenir des medicaments destines au traitement de l'obesite
US5795784A (en) 1996-09-19 1998-08-18 Abbott Laboratories Method of performing a process for determining an item of interest in a sample
US5856194A (en) 1996-09-19 1999-01-05 Abbott Laboratories Method for determination of item of interest in a sample
UA52681C2 (uk) * 1997-04-08 2003-01-15 Янссен Фармацевтика Н.В. Похідні 1,2,3,4-тетрагідро-бензофуро[3,2,-c]піридину, спосіб їх одержання та фармацевтична композиція на їх основі
UA70334C2 (en) 1998-10-06 2004-10-15 Janssen Pharmaceutica N V Jans BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS
ID28967A (id) * 1998-12-21 2001-07-19 Janssen Pharmaceutica Nv Benzisoksazol dan fenon sebagai alfa 2-antagonis
EP1147113B1 (en) 1999-01-19 2006-06-07 Neurosearch A/S Fused heterocyclic compounds and their use in the treatment of neurodegenerative diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2215948B1 (es) * 1973-02-01 1976-05-14 Centre Etd Ind Pharma
DD210278A5 (de) * 1982-03-05 1984-06-06 Boehringer Ingelheim Kg Verfahren zur herstellung neuer basisch substituierter 4-phenyl-4,5,6,7-tetrahydro-thieno-(2,3-c)pyridine

Also Published As

Publication number Publication date
FI853719L (fi) 1986-03-28
ZA857457B (en) 1986-05-28
FI853719A0 (fi) 1985-09-26
DK435285A (da) 1986-03-28
PT81206A (fr) 1985-10-01
NO853782L (no) 1986-04-01
CA1291994C (en) 1991-11-12
FI82054C (fi) 1991-01-10
FI82054B (fi) 1990-09-28
ATE40554T1 (de) 1989-02-15
IL76535A0 (en) 1986-02-28
EP0178201B1 (fr) 1989-02-01
FR2570701A1 (fr) 1986-03-28
PT81206B (pt) 1988-01-22
HUT38945A (en) 1986-07-28
DK158953C (da) 1991-01-14
NO162821C (no) 1990-02-21
AU573390B2 (en) 1988-06-09
DE3568045D1 (en) 1989-03-09
KR860002508A (ko) 1986-04-26
JPS61106577A (ja) 1986-05-24
FR2570701B1 (fr) 1987-05-22
DK158953B (da) 1990-08-06
AU4795285A (en) 1986-04-10
US4661498A (en) 1987-04-28
NZ213620A (en) 1988-01-08
NO162821B (no) 1989-11-13
GR852356B (es) 1986-01-28
ES547315A0 (es) 1986-03-16
DK435285D0 (da) 1985-09-26
HU192365B (en) 1987-05-28
EP0178201A1 (fr) 1986-04-16

Similar Documents

Publication Publication Date Title
AU1433588A (en) 1-phenyl-3-naphthalenyloxypropanamines
ES8707243A1 (es) Un procedimiento para preparar derivados de tienopiridona
ES8605522A1 (es) Un procedimiento para preparar derivados de furo (3,2-c) piridinas.
AU635779B2 (en) 3-aryloxazolidinone derivatives, process for their preparation and their use in therapy
IE872658L (en) Tetrahydroquinoline derivatives, a process for their preparation, their use and pharmaceutical formulations containing them
AU553859B2 (en) Tricyclic oxindole carboxamides
EP0186023A3 (en) Biliary acid derivatives, process for their preparation and pharmaceutical compositions containing them
ATE40127T1 (de) 1,5-benzothiazepinderivate, verfahren zu ihrer herstellung und arzneimittel.
AU1971788A (en) Piperidine derivatives, their preparation and their application in therapy
AU588656B2 (en) New fluorine-containing 1,4-dihydropyridines, process for their preparation and their use as medicaments
ES2004255A6 (es) Procedimiento de preparar compuestos del tipo de las piracinas y analogos.
IE881752L (en) New aminoacylates of glycerol acetal
MY101746A (en) 1,5-benzothiazepine derivatives, a process for preparing the same, pharmaceutical compositions as well as the use thereof.